{"resourceType":"Observation","id":"obr-2","text":{"status":"generated","div":"\u003cdiv xmlns\u003d\"http://www.w3.org/1999/xhtml\"\u003e\u003cp\u003e\u003cb\u003eGenerated Narrative\u003c/b\u003e\u003c/p\u003e\u003cdiv style\u003d\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"\u003e\u003cp style\u003d\"margin-bottom: 0px\"\u003eResource \u0026quot;obr-2\u0026quot; \u003c/p\u003e\u003c/div\u003e\u003cp\u003e\u003cb\u003estatus\u003c/b\u003e: final\u003c/p\u003e\u003cp\u003e\u003cb\u003ecode\u003c/b\u003e: Susceptibility - Automated broth dilution (Billed) \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e (panels#60790)\u003c/span\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003esubject\u003c/b\u003e: \u003ca href\u003d\"patient-example.html\"\u003ePatient/example\u003c/a\u003e \u0026quot;Peter CHALMERS\u0026quot;\u003c/p\u003e\u003cp\u003e\u003cb\u003eperformer\u003c/b\u003e: \u003cspan\u003e: Todd Ashby\u003c/span\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003ehasMember\u003c/b\u003e: \u003c/p\u003e\u003cul\u003e\u003cli\u003e\u003ca href\u003d\"todo.html\"\u003eObservation/obx2-1\u003c/a\u003e\u003c/li\u003e\u003cli\u003e\u003ca href\u003d\"todo.html\"\u003eObservation/obx2-2\u003c/a\u003e\u003c/li\u003e\u003cli\u003e\u003ca href\u003d\"todo.html\"\u003eObservation/obx2-4\u003c/a\u003e\u003c/li\u003e\u003cli\u003e\u003ca href\u003d\"todo.html\"\u003eObservation/obx2-6\u003c/a\u003e\u003c/li\u003e\u003cli\u003e\u003ca href\u003d\"todo.html\"\u003eObservation/obx2-8\u003c/a\u003e\u003c/li\u003e\u003cli\u003e\u003ca href\u003d\"todo.html\"\u003eObservation/obx2-10\u003c/a\u003e\u003c/li\u003e\u003cli\u003e\u003ca href\u003d\"todo.html\"\u003eObservation/obx2-12\u003c/a\u003e\u003c/li\u003e\u003cli\u003e\u003ca href\u003d\"todo.html\"\u003eObservation/obx2-14\u003c/a\u003e\u003c/li\u003e\u003cli\u003e\u003ca href\u003d\"todo.html\"\u003eObservation/obx2-16\u003c/a\u003e\u003c/li\u003e\u003cli\u003e\u003ca href\u003d\"todo.html\"\u003eObservation/obx2-18\u003c/a\u003e\u003c/li\u003e\u003cli\u003e\u003ca href\u003d\"todo.html\"\u003eObservation/obx2-20\u003c/a\u003e\u003c/li\u003e\u003cli\u003e\u003ca href\u003d\"todo.html\"\u003eObservation/obx2-22\u003c/a\u003e\u003c/li\u003e\u003cli\u003e\u003ca href\u003d\"todo.html\"\u003eObservation/obx2-24\u003c/a\u003e\u003c/li\u003e\u003cli\u003e\u003ca href\u003d\"todo.html\"\u003eObservation/obx2-26\u003c/a\u003e\u003c/li\u003e\u003cli\u003e\u003ca href\u003d\"todo.html\"\u003eObservation/obx2-28\u003c/a\u003e\u003c/li\u003e\u003cli\u003e\u003ca href\u003d\"todo.html\"\u003eObservation/obx2-30\u003c/a\u003e\u003c/li\u003e\u003cli\u003e\u003ca href\u003d\"todo.html\"\u003eObservation/obx2-32\u003c/a\u003e\u003c/li\u003e\u003cli\u003e\u003ca href\u003d\"todo.html\"\u003eObservation/obx2-34\u003c/a\u003e\u003c/li\u003e\u003cli\u003e\u003ca href\u003d\"todo.html\"\u003eObservation/nte-1\u003c/a\u003e\u003c/li\u003e\u003c/ul\u003e\u003c/div\u003e"},"status":"final","code":{"coding":[{"system":"http://acme.org/lab/codes/panels","code":"60790","display":"Susceptibility - Automated broth dilution (Billed)"}]},"subject":{"reference":"Patient/example"},"performer":[{"display":"Todd Ashby"}],"hasMember":[{"reference":"Observation/obx2-1"},{"reference":"Observation/obx2-2"},{"reference":"Observation/obx2-4"},{"reference":"Observation/obx2-6"},{"reference":"Observation/obx2-8"},{"reference":"Observation/obx2-10"},{"reference":"Observation/obx2-12"},{"reference":"Observation/obx2-14"},{"reference":"Observation/obx2-16"},{"reference":"Observation/obx2-18"},{"reference":"Observation/obx2-20"},{"reference":"Observation/obx2-22"},{"reference":"Observation/obx2-24"},{"reference":"Observation/obx2-26"},{"reference":"Observation/obx2-28"},{"reference":"Observation/obx2-30"},{"reference":"Observation/obx2-32"},{"reference":"Observation/obx2-34"},{"reference":"Observation/nte-1"}]}